4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow Tecfidera: new trials by email Literature Review of Tecfidera trials Research Report on Tecfidera
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis Dimethyl fumarate, Placebo - Primary Progressive Multiple Sclerosis | Phase 2 | Completed | Copenhagen University Hospital, Rigshospitalet | 54 | 2016-12-01 | 2020-12-24 |
| Dimethyl Fumarate for Obstructive Sleep Apnea Dimethyl fumarate, Placebo - Obstructive Sleep Apnea, OSA | Phase 2 | Completed | University of Michigan | 65 | 2015-05-01 | 2017-05-31 |
| Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis. dimethyl fumarate, tetanus diphtheria toxoids vaccine, 23-valent pneumococcal polysaccharide vaccine - Relapsing Forms of Multiple Sclerosis | Phase 2 | Completed | Biogen | 71 | 2015-02-28 | 2017-06-02 |
| BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis dimethyl fumarate - Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis | Phase 2 | Completed | Biogen | 108 | 2010-06-01 | 2017-03-21 |
Multiple Sclerosis (1) · Multiple Sclerosis, Chronic Progressive (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Sleep Apnea Syndromes (1) · Sleep Apnea, Obstructive (1) · Snoring (1)
Biogen (2) · Copenhagen University Hospital, Rigshospitalet (1) · University of Michigan (1)
United States (3) · Denmark (1)
Jacob Lando Talbot, MD (1) · Tiffany J. Braley, MD, MS (1)